GPRE FY2025 SEC EDGAR DEF 14A #99 of 168 in industry

Green Plains Inc. CEO pay ratio

The CEO earned $3.6M in FY2025 against median worker pay of $117,499 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
IA
Filing date
2026-04-24
Industry
Chemicals & Pharmaceuticals
Industry rank
#99/168

Data updated August 2026

Subscribe to Green Plains Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
31:1
Below Average (Scale: 0–1000:1)
CEO pay
$3.6M
Median worker
$117,499

Answer first

Green Plains Inc.'s FY2025 CEO total of $3.6M ranks #1033 of 1,423 complete filings; its 31:1 pay ratio ranks #1126. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $117,499. Industry placement uses the FY2025 SIC-28 peer cohort (# 99 of 168, 42nd percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1033
$3.6M of 1,423 FY2025
Ratio rank
#1126
31:1 of 1,423
Industry pct
42nd
below the industry median pay ratio

How Green Plains Inc. ranks nationally

Green Plains Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$3,642,469 27th percentile higher than 27% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Green Plains Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($3.6M) against pay ratio (31:1) for Green Plains Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3149280.95861815.4857435011286884.513999419.129.4:132.7:136:139.3:142.6:1CEO total payPay ratio (CEO : median worker)Green Plains Inc., CEO total pay: 3642469 · Pay ratio (CEO : median worker): 31:1Green Plains Inc.Iovance Biotherapeutics, Inc., CEO total pay: 4755679 · Pay ratio (CEO : median worker): 31:1Iovance Biotherapeutics, Inc.Protagonist Therapeutics, Inc, CEO total pay: 12852660 · Pay ratio (CEO : median worker): 30:1Protagonist Therapeutics, IncAlkermes plc., CEO total pay: 8002710 · Pay ratio (CEO : median worker): 30:1Alkermes plc.Janux Therapeutics, Inc., CEO total pay: 13506231 · Pay ratio (CEO : median worker): 30:1Janux Therapeutics, Inc.Recursion Pharmaceuticals, Inc., CEO total pay: 9503538 · Pay ratio (CEO : median worker): 33:1Recursion Pharmaceuticals, Inc.
Green Plains Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Green Plains Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Green Plains Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
31:1
FY2025
vs prior FY
-26:1
from FY2024 57:1
CEO $ YoY
-39%
$3.6M latest
Filings shown
5
FY2021–2025
Green Plains Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $5.9M - $85,066 69:1 -
2022 $5.9M -0% $93,309 63:1 -6:1
2023 $5.9M -0.4% $93,468 63:1 0:1
2024 $6.0M +2.6% $106,136 57:1 -6:1
2025 $3.6M -39% $117,499 31:1 -26:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1309402, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
31:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$3.6M
Companies in Industry
168
vs. Industry Median
Below
#99 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Green Plains Inc.: MODEST · MID$ pay ratio

Green Plains Inc.'s 31:1 ratio ranks #1126 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 31× the median employee ($117,499) in FY2025.

Median employee $117,499 (HIGH-MED); MODEST · MID$ stamps put about 31 median-wage years per CEO year.

CEO Total Pay

$3.6M

FY2025 Summary Compensation, below median

Pay Ratio

31:1

Below typical

Green Plains Inc. in the lower-ratio third

Green Plains Inc.'s 31:1 ratio ranks #1126 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Green Plains Inc.'s $3.6M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1033 and ratio rank #1126 split - treat 31:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$3.6M
Median Employee Pay
$117,499
Pay Ratio
31:1
Filing Date
2026-04-24

Company Info

Ticker
GPRE
CIK
1309402
Industry
Chemicals & Pharmaceuticals
SIC Code
2860
State
IA
View SEC filings →
SEC EDGAR DEF 14A for CIK 1309402, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Green Plains Inc.'s 31:1 ratio ranks #1126 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Green Plains Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · HIGH-MED.

Enterprise Financial Services Corp · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $12K heavier vs Green Plains Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · HIGH-MED.
Trustmark Corp · MID$

ABS(ceo_total_comp) peer at $3.7M (Δ $15K heavier vs Green Plains Inc.); MODEST · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Vital Farms, Inc. · MID$

ABS(ceo_total_comp) peer at $3.6M (Δ $26K lighter vs Green Plains Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · HIGH-MED.
Quanex Building Products CORP · MID$

ABS(ceo_total_comp) peer at $3.6M (Δ $29K lighter vs Green Plains Inc.); MODEST · PAR-MED vs this page's MODEST · MID$ · HIGH-MED.
Iovance Biotherapeutics, Inc. (SIC 28 pole)

Iovance Biotherapeutics, Inc. stamps MODEST · MID$ nearest in-SIC by ABS(pay_ratio) to Green Plains Inc.'s MODEST filing.
National dual ranks · #1033/#1126

Green Plains Inc.'s FY2025 package sits #1033 by CEO dollars and #1126 by ratio under MID$ · MODEST.
Ratio primer · MODEST

Green Plains Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Green Plains Inc. (CIK 1309402), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.